KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Current Liabilities (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Total Current Liabilities for 11 consecutive years, with $1.3 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities rose 23.29% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Sep 2025, up 23.29%, and an annual FY2024 reading of $1.1 billion, up 19.39% over the prior year.
  • Total Current Liabilities was $1.3 billion for Q3 2025 at Medpace Holdings, up from $1.2 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.3 billion in Q3 2025 and bottomed at $447.3 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $858.8 million, with a median of $880.4 million recorded in 2022.
  • The sharpest move saw Total Current Liabilities surged 85.98% in 2022, then decreased 3.02% in 2023.
  • Year by year, Total Current Liabilities stood at $557.2 million in 2021, then soared by 44.19% to $803.5 million in 2022, then grew by 15.14% to $925.1 million in 2023, then rose by 19.39% to $1.1 billion in 2024, then increased by 16.24% to $1.3 billion in 2025.
  • Business Quant data shows Total Current Liabilities for MEDP at $1.3 billion in Q3 2025, $1.2 billion in Q2 2025, and $1.1 billion in Q1 2025.